Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Fortuitous diagnosis of Trichomoniasis by PCR using panfungal primers.

Dupont D, Gaucherand P, Wallon M.

Int J Infect Dis. 2020 Jan;90:234-236. doi: 10.1016/j.ijid.2019.11.008. Epub 2019 Nov 11.

2.

The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis.

Binquet C, Lejeune C, Seror V, Peyron F, Bertaux AC, Scemama O, Quantin C, Béjean S, Stillwaggon E, Wallon M.

PLoS One. 2019 Sep 18;14(9):e0221709. doi: 10.1371/journal.pone.0221709. eCollection 2019.

3.

K3-EDTA differentially inhibits the growth of Candida strains according to their azole resistance status.

Dupont D, Tirard-Collet P, Persat F, Menotti J, Josse E, Wallon M, Pichon M.

Med Mycol. 2019 Jul 16. pii: myz080. doi: 10.1093/mmy/myz080. [Epub ahead of print]

PMID:
31309224
4.

Invasive Hepatobiliary Trichosporon asahii Infection in a Child With Autoimmune Cholangitis.

Noailly Charny PA, Rohmer B, Collardeau-Frachon S, Gillet Y, Dupont D, Wallon M, Lachaux A, Rabodonirina M.

J Pediatric Infect Dis Soc. 2019 Dec 27;8(6):574-577. doi: 10.1093/jpids/piz030. No abstract available.

PMID:
31107957
5.

Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group.

Peyron F, L'ollivier C, Mandelbrot L, Wallon M, Piarroux R, Kieffer F, Hadjadj E, Paris L, Garcia-Meric P.

Pathogens. 2019 Feb 18;8(1). pii: E24. doi: 10.3390/pathogens8010024.

6.

Plasmonic gold chips for the diagnosis of Toxoplasma gondii, CMV, and rubella infections using saliva with serum detection precision.

Li X, Pomares C, Peyron F, Press CJ, Ramirez R, Geraldine G, Cannavo I, Chapey E, Levigne P, Wallon M, Montoya JG, Dai H.

Eur J Clin Microbiol Infect Dis. 2019 May;38(5):883-890. doi: 10.1007/s10096-019-03487-1. Epub 2019 Jan 30.

PMID:
30701339
7.

Comparison of matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of moulds in the routine microbiology laboratory.

Dupont D, Normand AC, Persat F, Hendrickx M, Piarroux R, Wallon M.

Clin Microbiol Infect. 2019 Jul;25(7):892-897. doi: 10.1016/j.cmi.2018.10.013. Epub 2018 Oct 28.

PMID:
30394360
8.

Investigation of the Relationships Between Clinical and Environmental Isolates of Aspergillus fumigatus by Multiple-locus Variable Number Tandem Repeat Analysis During Major Demolition Work in a French Hospital.

Loeffert ST, Melloul E, Gustin MP, Hénaff L, Guillot C, Dupont D, Wallon M, Cassier P, Dananché C, Bénet T, Botterel F, Guillot J, Vanhems P.

Clin Infect Dis. 2019 Jan 7;68(2):321-329. doi: 10.1093/cid/ciy498.

PMID:
30247539
9.

Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies.

Lykins J, Li X, Levigne P, Zhou Y, El Bissati K, Clouser F, Wallon M, Morel F, Leahy K, El Mansouri B, Siddiqui M, Leong N, Michalowski M, Irwin E, Goodall P, Ismail M, Christmas M, Adlaoui EB, Rhajaoui M, Barkat A, Cong H, Begeman IJ, Lai BS, Contopoulos-Ioannidis DG, Montoya JG, Maldonado Y, Ramirez R, Press C, Peyron F, McLeod R.

PLoS Negl Trop Dis. 2018 Aug 16;12(8):e0006536. doi: 10.1371/journal.pntd.0006536. eCollection 2018 Aug. No abstract available.

10.

Acute respiratory distress syndrome and Plasmodium ovale malaria.

Guerpillon B, Boibieux A, Perpoint T, Allaouchiche B, Wallon M.

Travel Med Infect Dis. 2019 Mar - Apr;28:113-114. doi: 10.1016/j.tmaid.2018.06.002. Epub 2018 Jun 7. No abstract available.

PMID:
29886120
11.

Prospective survey of azole drug resistance among environmental and clinical isolates of Aspergillus fumigatus in a French University hospital during major demolition works.

Loeffert ST, Hénaff L, Dupont D, Bienvenu AL, Dananché C, Cassier P, Bénet T, Wallon M, Gustin MP, Vanhems P.

J Mycol Med. 2018 Sep;28(3):469-472. doi: 10.1016/j.mycmed.2018.05.007. Epub 2018 May 28.

PMID:
29853288
12.

Congenital Toxoplasmosis: A Plea for a Neglected Disease.

Wallon M, Peyron F.

Pathogens. 2018 Feb 23;7(1). pii: E25. doi: 10.3390/pathogens7010025.

13.

Experiences with and expectations of maternity waiting homes in Luapula Province, Zambia: a mixed-methods, cross-sectional study with women, community groups and stakeholders.

Chibuye PS, Bazant ES, Wallon M, Rao N, Fruhauf T.

BMC Pregnancy Childbirth. 2018 Jan 25;18(1):42. doi: 10.1186/s12884-017-1649-1.

14.

Comparison of immunoblotting (IgA and IgG) and the Goldmann-Witmer coefficient for diagnosis of ocular toxoplasmosis in immunocompetent patients.

Mathis T, Beccat S, Sève P, Peyron F, Wallon M, Kodjikian L.

Br J Ophthalmol. 2018 Oct;102(10):1454-1458. doi: 10.1136/bjophthalmol-2017-311528. Epub 2018 Jan 17.

PMID:
29343531
15.

Monitoring of clinical strains and environmental fungal aerocontamination to prevent invasive aspergillosis infections in hospital during large deconstruction work: a protocol study.

Loeffert ST, Melloul E, Dananché C, Hénaff L, Bénet T, Cassier P, Dupont D, Guillot J, Botterel F, Wallon M, Gustin MP, Vanhems P.

BMJ Open. 2017 Nov 25;7(11):e018109. doi: 10.1136/bmjopen-2017-018109.

16.

Donor Derived Candida stellimalicola in a Clinical Specimen: Preservation Fluid Contamination During Pancreas Procurement.

Dupont D, Huguenin A, Tisserand E, Reiter V, Morelon E, Badet L, Villena I, Wallon M, Toubas D.

Mycopathologia. 2018 Jun;183(3):573-577. doi: 10.1007/s11046-017-0171-3. Epub 2017 Jul 5.

PMID:
28681316
17.

Species of Metarhizium anisopliae complex implicated in human infections: retrospective sequencing study.

Nourrisson C, Dupont D, Lavergne RA, Dorin J, Forouzanfar F, Denis J, Weeks K, Joubert R, Chiambaretta F, Bourcier T, Roux S, Sénéchal A, Benaïm G, Wallon M, Candolfi E, Letscher-Bru V, Poirier P, Sabou M.

Clin Microbiol Infect. 2017 Dec;23(12):994-999. doi: 10.1016/j.cmi.2017.05.001. Epub 2017 May 6.

18.

Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches.

Peyron F, Mc Leod R, Ajzenberg D, Contopoulos-Ioannidis D, Kieffer F, Mandelbrot L, Sibley LD, Pelloux H, Villena I, Wallon M, Montoya JG.

PLoS Negl Trop Dis. 2017 Feb 16;11(2):e0005222. doi: 10.1371/journal.pntd.0005222. eCollection 2017 Feb. No abstract available.

19.

Evaluation of the LDBIO point of care test for the combined detection of toxoplasmic IgG and IgM.

Chapey E, Wallon M, Peyron F.

Clin Chim Acta. 2017 Jan;464:200-201. doi: 10.1016/j.cca.2016.10.023. Epub 2016 Oct 17.

PMID:
27765564
20.

Assessment of the diagnostic performance of the IDS-iSYS tests for toxo IgG, toxo IgM and avidity.

Levigne P, Peyron F, Wallon M.

Diagn Microbiol Infect Dis. 2016 Oct;86(2):148-52. doi: 10.1016/j.diagmicrobio.2016.07.006. Epub 2016 Jul 9.

PMID:
27450223
21.

Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.

Teil J, Dupont D, Charpiat B, Corvaisier S, Vial T, Leboucher G, Wallon M, Peyron F.

Pediatr Infect Dis J. 2016 Jun;35(6):634-8. doi: 10.1097/INF.0000000000001120.

PMID:
26906163
22.

Place of Interferon-γ Assay for Diagnosis of Congenital Toxoplasmosis.

Chapey E, Wallon M, L'Ollivier C, Piarroux R, Peyron F.

Pediatr Infect Dis J. 2015 Dec;34(12):1407-9. doi: 10.1097/INF.0000000000000901.

PMID:
26780025
23.

Effect of Antenatal Treatment on the Severity of Congenital Toxoplasmosis.

Wallon M, Peyron F.

Clin Infect Dis. 2016 Mar 15;62(6):811-2. doi: 10.1093/cid/civ1035. Epub 2015 Dec 21. No abstract available.

PMID:
26689954
24.

Landscape and climatic characteristics associated with human alveolar echinococcosis in France, 1982 to 2007.

Piarroux M, Gaudart J, Bresson-Hadni S, Bardonnet K, Faucher B, Grenouillet F, Knapp J, Dumortier J, Watelet J, Gerard A, Beytout J, Abergel A, Wallon M, Vuitton DA, Piarroux R; FrancEchino network.

Euro Surveill. 2015 May 7;20(18). pii: 21118.

25.

Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis.

Chapey E, Meroni V, Kieffer F, Bollani L, Ecochard R, Garcia P, Wallon M, Peyron F.

Clin Vaccine Immunol. 2015 Apr;22(4):398-403. doi: 10.1128/CVI.00552-14. Epub 2015 Feb 4.

26.

Cesarean delivery or induction of labor does not prevent vertical transmission of toxoplasmosis in late pregnancy.

Wallon M, Kieffer F, Huissoud C, Peyron F.

Int J Gynaecol Obstet. 2015 May;129(2):176-7. doi: 10.1016/j.ijgo.2014.10.026. Epub 2014 Dec 22. No abstract available.

PMID:
25556076
27.

Moving malaria in pregnancy programs from neglect to priority: experience from Malawi, Senegal, and Zambia.

Roman E, Wallon M, Brieger W, Dickerson A, Rawlins B, Agarwal K.

Glob Health Sci Pract. 2014 Jan 27;2(1):55-71. doi: 10.9745/GHSP-D-13-00136. eCollection 2014 Feb.

28.

Dermatophytes and transmission risks to family: a retrospective study of a cohort of 256 adopted children from 1998 to 2012.

Dupont D, Peyron F, Picot S, Wallon M, Bienvenu AL.

Pediatr Dermatol. 2015 May-Jun;32(3):426-7. doi: 10.1111/pde.12431. Epub 2014 Sep 18.

PMID:
25233935
29.

Surgical management of liver hydatid disease: subadventitial cystectomy versus resection of the protruding dome.

Mohkam K, Belkhir L, Wallon M, Darnis B, Peyron F, Ducerf C, Gigot JF, Mabrut JY.

World J Surg. 2014 Aug;38(8):2113-21. doi: 10.1007/s00268-014-2509-z.

PMID:
24969045
30.

Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence.

Wallon M, Garweg JG, Abrahamowicz M, Cornu C, Vinault S, Quantin C, Bonithon-Kopp C, Picot S, Peyron F, Binquet C.

Pediatrics. 2014 Mar;133(3):e601-8. doi: 10.1542/peds.2013-2153. Epub 2014 Feb 17.

PMID:
24534412
31.

Unusual growth rate during cystic echinococcosis.

Valour F, Khenifer S, Della-Schiava N, Cotte E, Guibert B, Wallon M, Durupt S, Durieu I.

Parasitol Int. 2014 Apr;63(2):275-7. doi: 10.1016/j.parint.2013.11.006. Epub 2013 Nov 22.

PMID:
24275211
32.

Congenital toxoplasmosis.

Kieffer F, Wallon M.

Handb Clin Neurol. 2013;112:1099-101. doi: 10.1016/B978-0-444-52910-7.00028-3. Review.

PMID:
23622316
33.

[Congenital toxoplasmosis: long-term ophthalmologic follow-up praised by patients].

Beraud L, Rabilloud M, Fleury J, Wallon M, Peyron F.

J Fr Ophtalmol. 2013 Jun;36(6):494-8. doi: 10.1016/j.jfo.2012.10.008. Epub 2013 Feb 19. French.

PMID:
23428138
34.

Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years.

Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Kopp CB, Binquet C.

Clin Infect Dis. 2013 May;56(9):1223-31. doi: 10.1093/cid/cit032. Epub 2013 Jan 29.

PMID:
23362291
35.

Comparison of mother and child antibodies that target high-molecular-mass Toxoplasma gondii antigens by immunoblotting improves neonatal diagnosis of congenital toxoplasmosis.

L'Ollivier C, Wallon M, Faucher B, Piarroux R, Peyron F, Franck J.

Clin Vaccine Immunol. 2012 Aug;19(8):1326-8. doi: 10.1128/CVI.00060-12. Epub 2012 Jun 13.

36.

Seasonal variations in acute toxoplasmosis in pregnant women in the Rhône-Alpes region (France).

Morin L, Lobry JR, Peyron F, Wallon M.

Clin Microbiol Infect. 2012 Oct;18(10):E401-3. doi: 10.1111/j.1469-0691.2012.03898.x. Epub 2012 May 23.

37.

[Congenital toxoplasmosis: randomised comparison of strategies for retinochoroiditis prevention].

Wallon M, Kieffer F, Binquet C, Thulliez P, Garcia-Méric P, Dureau P, Franck J, Peyron F, Bonnin A, Villena I, Bonithon-Kopp C, Gouyon JB, Masson S, Félin A, Cornu C.

Therapie. 2011 Nov-Dec;66(6):473-80. doi: 10.2515/therapie/2011070. Epub 2011 Dec 21. French.

PMID:
22186072
38.

Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes.

Ha NH, Nair VS, Reddy DN, Mudvari P, Ohshiro K, Ghanta KS, Pakala SB, Li DQ, Costa L, Lipton A, Badwe RA, Fuqua S, Wallon M, Prendergast GC, Kumar R.

Cancer Res. 2011 Dec 1;71(23):7259-69. doi: 10.1158/0008-5472.CAN-11-1143. Epub 2011 Oct 17.

39.

Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance.

Peyron F, Garweg JG, Wallon M, Descloux E, Rolland M, Barth J.

Pediatr Infect Dis J. 2011 Jul;30(7):597-600. doi: 10.1097/INF.0b013e31820bb5f3.

PMID:
21278618
40.

Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study.

Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE; European Multicentre Study on Congenital Toxoplasmosis (EMSCOT).

PLoS Med. 2010 Oct 12;7(10). pii: e1000351. doi: 10.1371/journal.pmed.1000351.

41.

Congenital toxoplasmosis in France in 2007: first results from a national surveillance system.

Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, Wallon M, King L, Goulet V; Toxosurv network and National Reference Centre for Toxoplasmosis.

Euro Surveill. 2010 Jun 24;15(25). pii: 19600.

42.

Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid.

Wallon M, Franck J, Thulliez P, Huissoud C, Peyron F, Garcia-Meric P, Kieffer F.

Obstet Gynecol. 2010 Apr;115(4):727-33. doi: 10.1097/AOG.0b013e3181d57b09.

PMID:
20308831
43.

In utero and at birth diagnosis of congenital toxoplasmosis: use of likelihood ratios for clinical management.

Rabilloud M, Wallon M, Peyron F.

Pediatr Infect Dis J. 2010 May;29(5):421-5. doi: 10.1097/INF.0b013e3181c80493.

PMID:
19952858
44.

Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay.

Chapey E, Wallon M, Debize G, Rabilloud M, Peyron F.

J Clin Microbiol. 2010 Jan;48(1):41-5. doi: 10.1128/JCM.01903-09. Epub 2009 Nov 18.

45.

Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France.

Cornu C, Bissery A, Malbos C, Garwig R, Cocherel C, Ecochard R, Peyron F, Wallon M.

Euro Surveill. 2009 Mar 5;14(9):21-5.

46.

Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe.

Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E; European Multicentre Study on Congenital Toxoplasmosis (EMSCOT).

PLoS Negl Trop Dis. 2008 Aug 13;2(8):e277. doi: 10.1371/journal.pntd.0000277.

47.

Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis.

Jamieson SE, de Roubaix LA, Cortina-Borja M, Tan HK, Mui EJ, Cordell HJ, Kirisits MJ, Miller EN, Peacock CS, Hargrave AC, Coyne JJ, Boyer K, Bessieres MH, Buffolano W, Ferret N, Franck J, Kieffer F, Meier P, Nowakowska DE, Paul M, Peyron F, Stray-Pedersen B, Prusa AR, Thulliez P, Wallon M, Petersen E, McLeod R, Gilbert RE, Blackwell JM.

PLoS One. 2008 Jun 4;3(6):e2285. doi: 10.1371/journal.pone.0002285.

48.

Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis.

Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J.

Pediatr Infect Dis J. 2008 Jan;27(1):27-32.

PMID:
18162934
49.

Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy.

Gollub EL, Leroy V, Gilbert R, Chêne G, Wallon M; European Toxoprevention Study Group (EUROTOXO).

Eur J Obstet Gynecol Reprod Biol. 2008 Feb;136(2):137-45. Epub 2007 Oct 30. Review.

PMID:
17977641
50.

Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth.

Gilbert RE, Thalib L, Tan HK, Paul M, Wallon M, Petersen E; European Multicentre Study on Congenital Toxoplasmosis.

J Med Screen. 2007;14(1):8-13.

PMID:
17362565

Supplemental Content

Loading ...
Support Center